1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA 2018;68:394–424.
2. Meza R, Meernik C, Jeon J, Cote ML. Lung cancer incidence trends by gender, race and histology in the United States, 1973–2010. PLoS One 2015;10:e0121323.
3. Sechler M, Cizmic AD, Avasarala S, Van Scoyk M, Brzezinski C, Kelley N, et al. Non-small-cell lung cancer: molecular targeted therapy and personalized medicine—drug resistance, mechanisms, and strategies. Pharmacogenomics Pers Med 2013;6:25–36.
4. Coussens LM, Laurence Z A Karolina P. Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 2013;339:286–291.
5. Candido J, Hagemann T. Cancer-related inflammation. J Clin Immunol 2013;33:S79–S84.